Search Within

Sujata Patil

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (278)
  2. Journal Article (230)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Biostatistics Service (511)
  2. Epidemiology and Biostatistics (511)
  3. Department of Medicine (363)
  4. Solid Tumor Oncology Division (358)
  5. Survivorship Research (323)
  6. Surgery (247)

More Groups

People
  1. Clifford Hudis (141)
  2. Larry Norton (97)
  3. Robert Motzer (93)
  4. Monica Morrow (83)
  5. Darren Feldman (81)
  6. Edi Brogi (65)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (24)
  5. 2020 (29)
  6. 2019 (31)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Annals of Surgical Oncology (67)
  3. Cancer Research (55)
  4. Cancer (23)
  5. Breast Cancer Research and Treatment (18)
  6. Clinical Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (172)
  2. Springer (92)
  3. American Association for Cancer Research (71)
  4. Elsevier Inc. (34)
  5. Wiley Blackwell (33)
  6. Oxford University Press (19)

More Publishers

Results (511)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcome and survival for patients (pts) with sarcomatoid-variant metastatic renal cell carcinoma (RCC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Molina, A. M.; Tickoo, S. K.; Ishill, N.; Trinos, M. J.; Schwartz, L. H.; Russo, P.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Determinants of outcome in elderly patients with positive sentinel lymph nodes
    Meeting Abstract

    Gemignani, M.; Karam, A.; Hsu, M.; Patil, S.; Stempel, M.; Traina, T.; Ho, A.; Cody, H. 3rd; Morrow, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts
    Meeting Abstract

    Feldman, D. R.; Sheinfeld, J.; Bajorin, D. F.; Fischer, P.; Turkula, S.; Ishill, N.; Patil, S.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Employment status among low-income Caucasian and Latina breast cancer survivors
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Diamant, A.; Thind, A.; Maly, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment
    Meeting Abstract

    Poultsides, G. A.; Servais, E. L.; Saltz, L. B.; Patil, S.; Kemeny, N. E.; Guillem, J. G.; Weiser, M.; Temple, L. K.; Wong, W.; Paty, P. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save